Isocarboxazid
An MAO inhibitor that is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in the treatment of panic disorder and the phobic disorders. (From AMA, Drug Evaluations Annual, 1994, p311)
Also Known As:
3-Isoxazolecarboxylic acid, 5-methyl-, 2-(phenylmethyl)hydrazide
Networked: 35
relevant articles (1 outcomes,
4 trials/studies)
Relationship Network
Drug Context: Research Results
Experts
1. | Abdelmoemin, Wegdan R:
1 article
(07/2022)
|
2. | Abraham, Magid M:
1 article
(07/2022)
|
3. | Amsterdam, Jay D:
1 article
(07/2022)
|
4. | Anderson, Ian M:
1 article
(07/2022)
|
5. | Andrade, Chittaranjan:
1 article
(07/2022)
|
6. | Baker, Glen B:
1 article
(07/2022)
|
7. | Beekman, Aartjan T F:
1 article
(07/2022)
|
8. | Berk, Michael:
1 article
(07/2022)
|
9. | Birkenhäger, Tom K:
1 article
(07/2022)
|
10. | Blackwell, Barry B:
1 article
(07/2022)
|
Related Diseases
Related Drugs and Biologics
Related Therapies and Procedures